Sanofi and Maze Deal for MZE001 Terminated Sanofi's agreement with Maze Therapeutics for the development of MZE001 was terminated following an FTC complaint. Explore the implications of this decision.
Sanofi Ends Maze Licensing Deal Over FTC Concerns Sanofi has terminated its global licensing agreement with Maze Therapeutics for Pompe disease treatment, citing issues related to FTC regulations.
FTC and NY Attorney General Accuse Handy of Deceptive Earnings Claims The FTC and New York's attorney general have accused Handy of falsely advertising worker earnings, raising concerns over deceptive labor practices.
Meta to Face FTC Trial Over Alleged Monopoly in April 2025 Meta is set for a trial with the FTC in April 2025 over monopoly allegations. Stay updated on this crucial antitrust case involving a tech giant.
Meta Shifts to Community Fact-Checking Amid FTC Trial Meta Platforms (META) ends third-party fact-checking, transitions to community-driven model, and prepares for FTC trial. Explore the implications.
Federal Judge Blocks Merger Over Competition Concerns A federal judge blocked a merger siding with the FTC over concerns of reduced competition, potential price hikes, and slower wage growth, impacting market dynamics.
FTC Restricts Non-Compete Clauses, Allows Paid Garden Leaves FTC bans non-compete clauses, permits mandatory garden leaves with full pay. Learn how this impacts job market dynamics and employee mobility.
FTC Fines accessiBe $1 Million for Misleading Ads The FTC has imposed a $1 million fine on accessiBe for deceptive advertising practices. Discover how this impacts the digital accessibility sector.
FTC Fines accessiBe $1M Over Misleading Ads and Undisclosed Reviews FTC fines accessiBe $1 million for misleading advertising and undisclosed sponsorships. Learn how these practices can impact consumer trust.
FTC Imposes $1 Million Fine on accessiBe FTC fines accessiBe $1 million, affecting its credibility and customer trust. Explore the implications for accessibility solutions and consumer protection.